dentro de ese espacio tienes otras, como caribou o beam, que tambien se han comentado por aqui en alguna ocasion
“Caribou is a leader in the CRISPR field, successfully leveraging its proprietary genome-editing technology to develop allogeneic cell therapies that are potentially transformative for patients.”
Jennifer Doudna, Ph.D.
Co-founder of Caribou
Beam is pioneering the use of base editing — a potential new class of precision genetic medicines — with a vision of providing life-long cures to patients suffering from serious diseases.
te recomiendo leas algo sobre los problemas del crspr "tradicional", o el double helix cut, y sobre base y prime editing.
